FEATURED POST

In the Bible Belt, Christmas Isn’t Coming to Death Row

Image
When it comes to the death penalty, guilt or innocence shouldn’t really matter to Christians.  

NASHVILLE — Until August, Tennessee had not put a prisoner to death in nearly a decade. Last Thursday, it performed its third execution in four months.
This was not a surprising turn of events. In each case, recourse to the courts had been exhausted. In each case Gov. Bill Haslam, a Republican, declined to intervene, though there were many reasons to justify intervening. Billy Ray Irick suffered from psychotic breaks that raised profound doubts about his ability to distinguish right from wrong. Edmund Zagorksi’s behavior in prison was so exemplary that even the warden pleaded for his life. David Earl Miller also suffered from mental illness and was a survivor of child abuse so horrific that he tried to kill himself when he was 6 years old.
Questions about the humanity of Tennessee’s lethal-injection protocol were so pervasive following the execution of Mr. Irick that both Mr. Zagorski and M…

Nebraska: Senator Chambers challenges Pfizer to stop any use of its drugs in execution

Pfizer logo
The letter begins: TIME IS OF THE ESSENCE.

With that, Omaha Sen. Ernie Chambers challenged a major drug company to use the courts to block use of any of its drugs that may be used in the scheduled execution of condemned Nebraska prisoner Carey Dean Moore.

Chambers sent the letter Friday to a Pfizer pharmaceutical company executive in an effort to persuade him to go beyond Pfizer's request to the Nebraska Department of Correctional Services for return of any lethal injection drugs manufactured by the company.

Another drug company, Alvogen, successfully filed a legal objection in Nevada this month to stop one of its drugs from being used in an execution. A judge blocked the use of its sedative midazolam from being used in the scheduled execution of Scott Raymond Dozier.

"Does Pfizer's desire to protect its integrity, good name and public image rise to the level of Alvogen's?" Chambers asked Robert Jones, Pfizer vice president of government affairs.

Moore is scheduled to die by lethal injection Aug. 14 and has been informed that four drugs, never before used in an execution in this combination, are to be administered to put him to death. They are fentanyl, diazepam, cisatracurium besylate and potassium chloride.

Jones sent a letter to Nebraska Corrections Director Scott Frakes in October asking for the return of any Pfizer products to be used for capital punishment.

The letter from Jones informed the department that diazepam and fentanyl had been added to the company's list of 11 restricted products from lethal injection for capital punishment. He requested the return of any restricted use Pfizer or Hospira products in the department's possession.

"Pfizer makes its products to enhance and save the lives of the patients we serve," Jones said in the letter. "Consistent with these values, Pfizer strongly objects to use of its products as lethal injections for capital punishment."

Nebraska, like some other states, has shrouded the source of its lethal injection drugs in secrecy, Chambers told Jones in the letter. ACLU of Nebraska, the Lincoln Journal Star and the Omaha World Herald have sued the state to compel it to reveal the sources of the drugs.

A Lancaster County District judge has ordered the state to release records of communications with its lethal injection drug suppliers, as well as several other documents related to Nebraska's efforts to carry out the death penalty.

The court found certain other documents were exempt from disclosure under a state law protecting the identities of members of the state's execution team, including purchase orders and chemical analysis reports.

The department appealed the decision and no records were released, so the source of the four drugs is still unknown.

In his letter, Chambers told Jones it was a puzzling fact that Pfizer had not initiated any legal action in Nebraska to force the department to return its drugs.

"The courts are open for business, as demonstrated by Alvogen; and I am confident that the judicial system will give serious, expeditious consideration to the goal of maintaining intact and unblemished and uncompromised by others Pfizer's declared mission and purpose -- 'to enhance and save the lives of patients' -- if you but initiate appropriate legal proceedings," Chambers wrote.

He questioned Pfizer's will to employ its "standing and legal wherewithal" to protect its interests in this situation.

Chambers said it might be understandable if a cynic were to suggest that Pfizer is being disingenuous and calculatingly trying to have it both ways, to stave off accusations of being complicit in executions, but by taking no legal action managing to continue active participation in the capital punishment market.

"What is Pfizer's good name worth?" he asked.

Jones, or a representative of Pfizer, could not be reached immediately for comment.

Source: Lincoln Journal Star, July 29, 2018


⚑ | Report an error, an omission, a typo; suggest a story or a new angle to an existing story; submit a piece, a comment; recommend a resource; contact the webmaster, contact us: deathpenaltynews@gmail.com.


Opposed to Capital Punishment? Help us keep this blog up and running! DONATE!



"One is absolutely sickened, not by the crimes that the wicked have committed,
but by the punishments that the good have inflicted." -- Oscar Wilde

Most Viewed (Last 7 Days)

Florida executes Jose Jimenez

Iran: Billionaire To Be Hanged After Government Collects His Money

Prisoner executions in Belarus ‘simply unacceptable’, says UN rights body

Opinion: Jerry Brown Has the Power to Save 740 Lives. He Should Use It.

The Electric Chair Is Back and the Death Penalty Is on Life Support

As next execution looms, Florida debates the drugs it uses to kill

Iran: Prisoner hanged in Mashhad

Lukashenko: Decision on capital punishment should be made by people

20 Minutes to Death: Record of the Last Execution in France

The slow death of the death penalty in the U.S.